Saturday, 11 April 2026
PERSPECTA
News from every angle
All
World
Politics
Business
Technology
Finance
Science
Health
Culture
Opinion
Environment
← Back to headlines
ImmunityBio Inc. (IBRX) Announces Approval for ANKTIVA® in Macau SAR, China
25 Mar, 14:52 — 25 Mar, 14:52
Post
Share
Copy link
Embed
Sources
Sort: Relevance
Sort: Latest
Sort: Bias (L→R)
Sort: Bias (R→L)
Sort: Factuality
left
center
right
Showing 1 of 1 sources
Yahoo
Mostly Factual
17d ago
ImmunityBio Inc. (IBRX) Announces Approval for ANKTIVA® in Macau SAR, China
Read full article →
Something wrong with this story? Report an issue
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Four Arrested for Selling P102 Million in Counterfeit Anti-Cancer Medicine in Makati
15m ago
Japan to Improve Treatment of Technical Staff in Research Institutions
25m ago
Ethiopian Factory Transforms Old Tires into Shoes
28m ago
Saturday, 11 April 2026
Explore
Log in
Sign up
en
PERSPECTA
News from every angle
